K
Keith Rolles
Researcher at Royal Free Hospital
Publications - 171
Citations - 9934
Keith Rolles is an academic researcher from Royal Free Hospital. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 52, co-authored 171 publications receiving 9671 citations. Previous affiliations of Keith Rolles include University of Cambridge & Universidade Federal de Minas Gerais.
Papers
More filters
Journal ArticleDOI
Cyclosporin a initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers
R.Y. Calne,Keith Rolles,Sathia Thiru,McMaster P,G.N. Craddock,S. Aziz,D.J.G. White,D. B. Evans,D.C Dunn,R.G. Henderson,P. Lewis +10 more
TL;DR: 34 patients treated with cyclosporin A received 36 cadaveric organ allografts, 26 kidneys are still supporting life, 3 after more than a year; the pancreases and livers are also functioning.
Journal ArticleDOI
Cyclosporin A in patients receiving renal allografts from cadaver donors.
R. Y. Calne,Sathia Thiru,McMaster P,G.N. Craddock,D.J.G. White,D. B. Evans,D.C Dunn,B.D Pentlow,Keith Rolles +8 more
TL;DR: Seven patients on dialysis with renal failure received transplants from mismatched cadaver donors and were treated with cyclosporin A (CyA), initially as the sole immunosuppressive agent but there was clear evidence of both nephrotoxicity and hepatotoxicity.
Journal ArticleDOI
Liver transplantation for malignant disease. Results in 93 consecutive patients.
TL;DR: Despite the overall high frequency of tumor recurrence in most categories of hepatic malignancy, liver transplantation gave worthwhile survival with a number of patients cured and in the others considerable palliation of symptoms.
Journal ArticleDOI
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
Leonie Grellier,David Mutimer,M. M. Ahmed,Dave Brown,Andrew K. Burroughs,Keith Rolles,Paul McMaster,P Beranek,F Kennedy,H Kibbler,Penny McPhillips,Elwyn Elias,Geoff Dusheiko +12 more
TL;DR: Lamivudine treatment may prove useful in preventing recurrence of hepatitis B after liver transplantation and the effect on survival of patients after transplantation remains to be assessed.
Journal ArticleDOI
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome.
Andrew K. Burroughs,Caroline A. Sabin,Keith Rolles,Valérie Delvart,Vincent Karam,John A. C. Buckels,John O'Grady,Denis Castaing,Jürgen Klempnauer,Neville V. Jamieson,Peter Neuhaus,Jan Lerut,Jean de Ville de Goyet,Stephen Pollard,Mauro Salizzoni,Xavier Rogiers,Ferdinand Mühlbacher,Juan Carlos Garcia Valdecasas,C. E. Broelsch,Daniel Jaeck,Joaquín Berenguer,Enrique Moreno González,R. Adam +22 more
TL;DR: The 3-month and 12-month mortality models can be effectively used to assess outcomes both within and between centres, and provide a means of assessing the risk of post-transplantation mortality, giving clinicians important data to base strategic decisions about transplant policy in particular individuals or groups.